ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Using RWE To Get To Insights And Action — Faster

  Delve into three examples that vividly showcase the formidable power of real-world evidence from the early stages of drug development through clinical trials and commercialization.

• The Future Of Data Linkage In Clinical Trial Evidence Generation

  Explore key questions about the future of AI and data linkage in clinical trial evidence generation.

• Biosample Tracking: A Consenting Dilemma

  Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.

• RWD/RWE In 2023: Regulatory Policy World Tour

  Learn about what the industry considers RWD/RWE priorities for the year, as well as current efforts being taken within each region around the globe.

• An Expert's View On Choosing And Developing An eCOA Strategy

  Dive into the insights from our recent LinkedIn Live discussion where we explored how a standardized approach to eCOA could transform clinical trials and streamline data collection.

• Revolutionizing Pediatric Clinical Trials With ePRO And eConsent

  Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.

• Early-Stage Biotech's AI Advantage Is A Window That Closes

  The "greenfield" advantage allows biotechs to build AI-native trials from the start, replacing manual data entry with automated workflows and structured human oversight for better data integrity.

• How AI And ML Can Transform Clinical Trial Conduct

  There’s no doubt that 2023 will be remembered as the year that artificial intelligence and machine learning became mainstream. Gain an overview of the uses of AI and ML in clinical conduct.

• 5 Features to Look for in Your Next eTMF

  Not every electronic trial master file will provide the robust support and compliance measures required. When searching for a successful solution, make sure the eTMF of interest has these five features.

• What Happened At ASCO 2024

  Discover our associates' insights on the key developments from ASCO 2024 that are set to shape the future of cancer care and patient outcomes.